We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Strep B Genome Yields Surprising Diversity

By Biotechdaily staff writers
Posted on 12 Sep 2002
Researchers have published the complete genome sequence for the pathogenic bacterium Streptococcus agalactiae (also known as group B streptococcus or strep B), which is a major cause of pneumonia and meningitis in newborns and the source of life-threatening illnesses in a growing number of adults with deficient immune systems. More...
The research was reported in the August 28, 2002, online edition of the Proceedings of the National Academy of Sciences.

As part of the study, investigators from The Institute for Genomic Research (Rockville, MD, USA; www.tigr.org) compared the genome of the ‘serotype V' isolate of S agalactiae--the most common capsule type that is associated with invasive infection among adults other than pregnant women--to the genetic makeup of other S agalactiae strains and also to two different species of streptococci (S pneumoniae and S pyogenes) that cause diseases in humans.

S agalactiae has a circular genome of about 2.16 million base pairs. Researchers predicted that there would be 2,176 genes in that genome, and about 65% of the proteins expressed by those genes were of known function. The authors of the current study found that the three streptococcal species shared 1,060 genes, about half of their genes, but that 683 genes were unique to S agalactiae.

"We were surprised to find so many differences among the isolates of this important pathogen, said the study's first author, Dr. Herve Tettelin, an associate investigator at The Institute for Genomic Research. "Those differences could help explain why some strains of S agalactiae are much more virulent than others.”

Dr. Tettelin said the microarray experiments that compared those related genomes found numerous differences, even among strains with the same serotype. For example variations exist in the type of polysaccharides that make up the capsule that surrounds each bacterium. Furthermore, the S agalactiae genome differed from that of other streptococci in several of the microbe's metabolic pathways and in related transport systems through the bacterium's cell membrane. The researchers also found unique genes in S agalactiae related to surface proteins, capsule synthesis, and the hemolysin enzyme.



Related Links:
The Institute for Genomic Research

New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Gold Member
Genetic Type 1 Diabetes Risk Test
T1D GRS Array
Laboratory Software
ArtelWare
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Industry experts gather at WHX Labs Dubai to discuss how leadership must adapt as AI and automation transform the laboratory (Photo courtesy of Shutterstock)

WHX Labs in Dubai spotlights leadership skills shaping next-generation laboratories

WHX Labs in Dubai (formerly Medlab Middle East), held at Dubai World Trade Centre (DWTC) from 10–13 February, brings together international experts to discuss the factors redefining laboratory leadership,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.